DrugPatentWatch Database Preview
Drugs in Development Information for Tasisulam
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Tasisulam?
Tasisulam is an investigational drug.
There have been 11 clinical trials for Tasisulam.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Melanoma, Carcinoma, Non-Small-Cell Lung, and Breast Neoplasms. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Summary for Tasisulam
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-12-01) |
| Vendors | 55 |
Recent Clinical Trials for Tasisulam
| Title | Sponsor | Phase |
|---|---|---|
| A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients | Eli Lilly and Company | Phase 1 |
| A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma | Eli Lilly and Company | Phase 1 |
| A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma | Eli Lilly and Company | Phase 3 |
Clinical Trial Summary for Tasisulam
Top disease conditions for Tasisulam
Top clinical trial sponsors for Tasisulam
US Patents for Tasisulam
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
